한글목차

동물용 항생제 및 항균제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 56억 4,000만 달러에서 2026년에는 60억 5,000만 달러로, CAGR 7.3%로 확대될 것으로 예상됩니다. 지난 수년간의 성장에는 가축 사육두수 증가, 동물 전염병의 확산, 상업적 축산의 성장, 수의학 인프라의 확충, 성장 촉진 목적으로의 항생제 사용의 역사 등이 요인으로 꼽힙니다.

동물용 항생제 및 항균제 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 80억 3,000만 달러에 달하고, CAGR은 7.3%를 기록할 전망입니다. 예측 기간의 성장 요인으로는 항균제 내성 규제 강화, 안전한 동물성 식품에 대한 수요 확대, 반려동물 사육 증가, 동물용 의약품 연구개발 투자 증가, 예방적 동물 건강관리 관행 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 정밀 수의학 도입, 지속가능한 축산 건강 관리, 항균제 사용의 디지털 모니터링, 수의용 항생제를 위한 AI를 활용한 신약 개발, 동물용 의약품의 스마트 제조 등이 있습니다.

동물 유래 식품에 대한 수요 확대가 동물용 항생제 및 항균제 시장의 성장을 견인하고 있습니다. 우유, 계란, 육류 등의 제품은 중요한 영양 공급원이며, 인간의 식생활에서 없어서는 안 될 중요한 역할을 하고 있습니다. 이러한 동물성 식품을 생산하는 기업 및 기관들은 예방적 조치로 동물용 항생제 및 항균제를 활용하여 건강하고 질병이 없는 가축군을 육성하는 데 주력하고 있습니다. 예를 들어, 2023년 6월 유엔식량농업기구(FAO)가 발표한 보고서에 따르면 2023년 세계 육류 생산량은 전년 대비 0.8%의 완만한 증가가 예상되며, 3억 6,500만 톤(도체 중량 환산)에 달할 것으로 전망됩니다. 따라서 예측 기간 동안 동물성 식품에 대한 수요 증가가 동물용 항생제 및 항균제의 수요 확대를 견인할 것으로 예상됩니다.

동물용 항생제 및 항균제 시장의 주요 기업들은 동물의 건강, 생산성 및 항균제 내성에 대한 우려가 높아지는 가운데 효과적인 질병 관리 솔루션에 대한 수요 증가에 대응하기 위해 치료 효과 향상, 다양한 축종에 대한 투여 간소화, 새로운 주사제형 다품종 치료제와 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 솔루션 개발에 주력하고 있습니다. 신규 주사제형 다품종 치료제는 소, 돼지, 양, 염소, 양, 염소 등 여러 동물 종에 안전하고 효과적으로 사용할 수 있도록 고안된 주사제를 말합니다. 특정 단일 종에 국한된 것이 아닙니다. 예를 들어, 2025년 2월, 미국에 본사를 둔 동물용 의약품 기업 엘랑코 애니멀 헬스(Elanco Animal Health)는 소 호흡기질환(BRD) 및 돼지 호흡기질환(SRD) 치료에 특화된 혁신적인 항생제 '프라닥렉스(Pradrex, 프라도플록사신 주사제)'를 출시하였습니다. 이는 약 20년 만에 미국 식품의약국(FDA)이 승인한 이러한 적응증에 대한 새로운 분자구조를 가진 주사제 항생제입니다. 프라닥렉스의 새로운 작용 기전은 주요 BRD 및 SRD 박테리아에 대한 종합적인 커버리지를 실현하고, 투여 후 신속하게 높은 치료 농도를 달성합니다. 또한, 업계 최고의 휴약 기간을 특징으로 하며, 농장의 통합적인 질병 관리 프로그램에 적합하면서 효과와 생산자의 편의성을 모두 향상시킵니다. 이번 출시는 시장 관계자들이 중요한 가축 건강 문제를 해결하고, 동물 복지를 개선하고, 지속가능한 생산 시스템을 지원하기 위해 항균 요법을 어떻게 추진하고 있는지를 강조합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Animal antibiotics and antimicrobials refer to veterinary medications designed to combat bacteria or microorganisms by either killing them or limiting their growth and multiplication. These medications serve various purposes in animals, including the treatment of clinical diseases, prevention or control of common disease events, and the enhancement of animal growth.

The main types of animal antibiotics and antimicrobials encompass tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. Tetracyclines, for example, are bacteriostatic and function by reversibly binding to bacterial 30S ribosomes, thereby altering the bacterial cytoplasmic membrane. Tetracyclines are administered in various forms, including premixes, oral powder, oral solutions, and injections. These medications find use in both companion and food-producing animals.

Tariffs have influenced the animal antibiotics and antimicrobials market by increasing the cost of imported active pharmaceutical ingredients, veterinary formulations, and manufacturing inputs, thereby impacting pricing and supply stability. The effects are most pronounced in antibiotic-heavy segments such as tetracyclines, penicillin, and cephalosporins, and in regions reliant on imports, including asia-pacific and latin america. Higher tariffs have pressured manufacturers to localize production and diversify sourcing, while also encouraging domestic pharmaceutical capacity expansion. In the long term, tariffs may support regional manufacturing growth and reduce dependency on cross-border antibiotic supply chains.

The animal antibiotics and antimicrobials market research report is one of a series of new reports from The Business Research Company that provides animal antibiotics and antimicrobials market statistics, including animal antibiotics and antimicrobials industry global market size, regional shares, competitors with a animal antibiotics and antimicrobials market share, detailed animal antibiotics and antimicrobials market segments, market trends and opportunities, and any further data you may need to thrive in the animal antibiotics and antimicrobials industry. This animal antibiotics and antimicrobials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal antibiotics and antimicrobials market size has grown strongly in recent years. It will grow from $5.64 billion in 2025 to $6.05 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to rising livestock population, increasing prevalence of animal infectious diseases, growth of commercial animal farming, expanding veterinary healthcare infrastructure, historical use of antibiotics for growth promotion.

The animal antibiotics and antimicrobials market size is expected to see strong growth in the next few years. It will grow to $8.03 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to stricter regulations on antimicrobial resistance, growing demand for safe animal-derived food products, increasing companion animal ownership, rising investment in veterinary drug r&d, expansion of preventive animal healthcare practices. Major trends in the forecast period include precision veterinary medicine adoption, sustainable livestock health management, digital monitoring of antimicrobial usage, ai-enabled drug discovery for veterinary antibiotics, smart manufacturing of veterinary pharmaceuticals.

The growing demand for animal-derived food products is fueling the expansion of the animal antibiotics and antimicrobials market. Products such as milk, eggs, and meat are significant sources of nutrition and play a vital role in human diets. Companies and institutions involved in producing these animal-derived foods are concentrating on developing healthy or disease-free herds by using animal antibiotics and antimicrobials as a precautionary measure. For example, a report released by the Food and Agriculture Organization (FAO) in June 2023 indicates that global meat production is expected to rise modestly by 0.8 percent in 2023, reaching 365 million tonnes (carcass weight equivalent) compared to 2022. Consequently, the increasing demand for animal-derived food products is anticipated to drive the demand for animal antibiotics and antimicrobials during the forecast period.

Key players operating in the animal antibiotics and antimicrobials market are focusing on developing innovative solutions, such as novel injectable multi-species treatments, to enhance therapeutic efficacy, improve ease of administration across different livestock species, and address the growing demand for effective disease management solutions amid rising concerns over animal health, productivity, and antimicrobial resistance. A novel injectable multi-species treatment refers to a newly developed injectable medication that is designed to be safely and effectively used across multiple animal species, such as cattle, swine, sheep, or goats, rather than being limited to a single species. For instance, in February 2025, Elanco Animal Health Incorporated, a US-based animal health company, launched Pradalex (pradofloxacin injection), an innovative antibiotic specifically indicated for the treatment of bovine respiratory disease (BRD) and swine respiratory disease (SRD), marking the first new molecule and injectable antibiotic for these indications approved by the U.S. FDA in roughly two decades. Pradalex's novel mode of action enables comprehensive coverage against major BRD and SRD bacteria, delivers high therapeutic concentrations rapidly post-injection, and features an industry-leading withdrawal period, enhancing both efficacy and producer convenience while fitting into integrated disease management programs on farms. This launch underscores how market players are advancing antimicrobial therapies to address significant livestock health challenges, improve animal welfare, and support sustainable production systems.

In July 2024, Merck Sharp & Dohme LLC, a US-based provider of veterinary pharmaceuticals, vaccines, biologicals, and health solutions for livestock, companion animals, and aquaculture, acquired Elanco Animal Health Incorporated's aqua business for an undisclosed amount. With this acquisition, Merck Animal Health aimed to significantly strengthen and scale its global aquaculture portfolio, expand its presence in high-growth aquatic species markets, and enhance its long-term growth strategy in fish health and sustainability solutions. Elanco Animal Health Incorporated is a US-based provider of aquaculture health products, offering vaccines, therapeutics, and nutritional solutions designed to prevent and treat diseases in farmed fish across major aquaculture regions worldwide.

Major companies operating in the animal antibiotics and antimicrobials market are C. H. Boehringer Sohn AG & Co. KG, Zoetis Inc., Elanco Animal Health Inc., Merck & Co. Inc., Phibro Animal Health Corp., Ashish Life Science Pvt. Limited, Ayurvet Limited, Dechra Pharmaceuticals Plc, Huvepharma Inc., Inovet (V. M. D. nv/sa), Kyoritsu Seiyaku Corporation, Lutim Pharma Private Limited, Neogen Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., UCBVET Animal Health, Vetoquinol, Virbac, Zydus Animal Health Limited, China Animal Husbandry Co. Ltd., Norbrook Laboratories Limited, Biovet AD - Peshtera, Bio Agri Mix LP, Bioiberica S. A. U., Ceva Sante Animale

North America was the largest region in the animal antibiotics and antimicrobials market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the animal antibiotics and antimicrobials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The animal antibiotics and antimicrobials market consists of sales of glycopeptides, B-Lactam antibiotics, and polymixins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Antibiotics and Antimicrobials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses animal antibiotics and antimicrobials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal antibiotics and antimicrobials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal antibiotics and antimicrobials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type Of Product: Tetracyclines; Penicillin; Sulfonamides; Macrolides; Aminoglycosides; Lincosamides; Fluoroquinolones; Cephalosporins; Other Type Of Products
• 2) By Mode Of Delivery: Premixes; Oral Powder; Oral Solution; Injection; Other Modes Of Delivery
• 3) By Animal Type: Food-Producing Animals; Companion Animals
• Subsegments:
• 1) By Tetracyclines: Oxytetracycline; Chlortetracycline; Doxycycline
• 2) By Penicillin: Penicillin G; Ampicillin; Amoxicillin
• 3) By Sulfonamides: Sulfadimidine; Sulfadiazine; Sulfamethoxazole
• 4) By Macrolides: Erythromycin; Tylosin; Tulathromycin
• 5) By Aminoglycosides: Gentamicin; Neomycin; Streptomycin
• 6) By Lincosamides: Lincomycin; Clindamycin
• 7) By Fluoroquinolones: Enrofloxacin; Marbofloxacin; Ciprofloxacin
• 8) By Cephalosporins: Cefquinome; Cephalexin; Cefoperazone
• 9) By Other Type Of Products: Nitrofurans; Phenicols
• Companies Mentioned: C. H. Boehringer Sohn AG & Co. KG; Zoetis Inc.; Elanco Animal Health Inc.; Merck & Co. Inc.; Phibro Animal Health Corp.; Ashish Life Science Pvt. Limited; Ayurvet Limited; Dechra Pharmaceuticals Plc; Huvepharma Inc.; Inovet (V. M. D. nv/sa); Kyoritsu Seiyaku Corporation; Lutim Pharma Private Limited; Neogen Corporation; Tianjin Ringpu Bio-Technology Co. Ltd.; UCBVET Animal Health; Vetoquinol; Virbac; Zydus Animal Health Limited; China Animal Husbandry Co. Ltd.; Norbrook Laboratories Limited; Biovet AD - Peshtera; Bio Agri Mix LP; Bioiberica S. A. U.; Ceva Sante Animale
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Animal Antibiotics and Antimicrobials Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Animal Antibiotics and Antimicrobials Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Animal Antibiotics and Antimicrobials Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Animal Antibiotics and Antimicrobials Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Precision Veterinary Medicine Adoption
  • 4.2.2 Sustainable Livestock Health Management
  • 4.2.3 Digital Monitoring Of Antimicrobial Usage
  • 4.2.4 Ai-Enabled Drug Discovery For Veterinary Antibiotics
  • 4.2.5 Smart Manufacturing Of Veterinary Pharmaceuticals

5. Animal Antibiotics and Antimicrobials Market Analysis Of End Use Industries

• 5.1 Veterinary Hospitals And Clinics
• 5.2 Livestock Farms And Commercial Animal Producers
• 5.3 Poultry Farms
• 5.4 Aquaculture Farms
• 5.5 Animal Feed Manufacturers

6. Animal Antibiotics and Antimicrobials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Animal Antibiotics and Antimicrobials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Animal Antibiotics and Antimicrobials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Animal Antibiotics and Antimicrobials Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Animal Antibiotics and Antimicrobials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Animal Antibiotics and Antimicrobials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Animal Antibiotics and Antimicrobials Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Animal Antibiotics and Antimicrobials Market Segmentation

• 9.1. Global Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Type Of Products
• 9.2. Global Animal Antibiotics and Antimicrobials Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Premixes, Oral Powder, Oral Solution, Injection, Other Modes Of Delivery
• 9.3. Global Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Food-Producing Animals, Companion Animals
• 9.4. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Tetracyclines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oxytetracycline, Chlortetracycline, Doxycycline
• 9.5. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Penicillin G, Ampicillin, Amoxicillin
• 9.6. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sulfadimidine, Sulfadiazine, Sulfamethoxazole
• 9.7. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Erythromycin, Tylosin, Tulathromycin
• 9.8. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gentamicin, Neomycin, Streptomycin
• 9.9. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Lincosamides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lincomycin, Clindamycin
• 9.10. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enrofloxacin, Marbofloxacin, Ciprofloxacin
• 9.11. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cefquinome, Cephalexin, Cefoperazone
• 9.12. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Other Type Of Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nitrofurans, Phenicols

10. Animal Antibiotics and Antimicrobials Market Regional And Country Analysis

• 10.1. Global Animal Antibiotics and Antimicrobials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Animal Antibiotics and Antimicrobials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Animal Antibiotics and Antimicrobials Market

• 11.1. Asia-Pacific Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Animal Antibiotics and Antimicrobials Market

• 12.1. China Animal Antibiotics and Antimicrobials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Animal Antibiotics and Antimicrobials Market

• 13.1. India Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Animal Antibiotics and Antimicrobials Market

• 14.1. Japan Animal Antibiotics and Antimicrobials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Animal Antibiotics and Antimicrobials Market

• 15.1. Australia Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Animal Antibiotics and Antimicrobials Market

• 16.1. Indonesia Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Animal Antibiotics and Antimicrobials Market

• 17.1. South Korea Animal Antibiotics and Antimicrobials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Animal Antibiotics and Antimicrobials Market

• 18.1. Taiwan Animal Antibiotics and Antimicrobials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Animal Antibiotics and Antimicrobials Market

• 19.1. South East Asia Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Animal Antibiotics and Antimicrobials Market

• 20.1. Western Europe Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Animal Antibiotics and Antimicrobials Market

• 21.1. UK Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Animal Antibiotics and Antimicrobials Market

• 22.1. Germany Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Animal Antibiotics and Antimicrobials Market

• 23.1. France Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Animal Antibiotics and Antimicrobials Market

• 24.1. Italy Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Animal Antibiotics and Antimicrobials Market

• 25.1. Spain Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Animal Antibiotics and Antimicrobials Market

• 26.1. Eastern Europe Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Animal Antibiotics and Antimicrobials Market

• 27.1. Russia Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Animal Antibiotics and Antimicrobials Market

• 28.1. North America Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Animal Antibiotics and Antimicrobials Market

• 29.1. USA Animal Antibiotics and Antimicrobials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Animal Antibiotics and Antimicrobials Market

• 30.1. Canada Animal Antibiotics and Antimicrobials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Animal Antibiotics and Antimicrobials Market

• 31.1. South America Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Animal Antibiotics and Antimicrobials Market

• 32.1. Brazil Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Animal Antibiotics and Antimicrobials Market

• 33.1. Middle East Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Animal Antibiotics and Antimicrobials Market

• 34.1. Africa Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Animal Antibiotics and Antimicrobials Market, Segmentation By Type Of Product, Segmentation By Mode Of Delivery, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Animal Antibiotics and Antimicrobials Market Regulatory and Investment Landscape

36. Animal Antibiotics and Antimicrobials Market Competitive Landscape And Company Profiles

• 36.1. Animal Antibiotics and Antimicrobials Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Animal Antibiotics and Antimicrobials Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Animal Antibiotics and Antimicrobials Market Company Profiles
  • 36.3.1. C. H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Phibro Animal Health Corp. Overview, Products and Services, Strategy and Financial Analysis

37. Animal Antibiotics and Antimicrobials Market Other Major And Innovative Companies

• Ashish Life Science Pvt. Limited, Ayurvet Limited, Dechra Pharmaceuticals Plc, Huvepharma Inc., Inovet (V. M. D. nv/sa), Kyoritsu Seiyaku Corporation, Lutim Pharma Private Limited, Neogen Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., UCBVET Animal Health, Vetoquinol, Virbac, Zydus Animal Health Limited, China Animal Husbandry Co. Ltd., Norbrook Laboratories Limited

38. Global Animal Antibiotics and Antimicrobials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Animal Antibiotics and Antimicrobials Market

40. Animal Antibiotics and Antimicrobials Market High Potential Countries, Segments and Strategies

• 40.1 Animal Antibiotics and Antimicrobials Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Animal Antibiotics and Antimicrobials Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Animal Antibiotics and Antimicrobials Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer